Madhur K. Garg, MD, MBA, MBBS, discusses the safety of proton therapy in patients with head and neck cancer.
Madhur Garg, MD, MBA, FACR
Advertisement
Madhur Garg, MD, MBA, FACR, of Montefiore Einstein
Articles by Madhur Garg, MD, MBA, FACR
Madhur K. Garg, MD, MBA, MBBS, discusses findings from a phase 3 study of proton therapy in patients with head and neck cancer.
Madhur K. Garg, MD, MBA, MBBS, discusses the use of proton therapy in head and neck cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Ifinatamab Deruxtecan BLA Voluntarily Withdrawn in Previously Treated Extensive-Stage SCLC
2
Long-Term PERSEUS Data Confirm Durable PFS Benefit With D-VRd in Transplant-Eligible Newly Diagnosed Myeloma
3
FDA Approves Lirafugratinib for Pretreated, Locally Advanced or Metastatic Cholangiocarcinoma
4
Dr Voorhees on Eligibility Criteria for the CERVINO Trial in Multiple Myeloma
5